Insmed INSM 深 沪
等待开盘 10-02 09:30:00 美东时间
108.59
-5.550
-4.86%
华盛通- 最 高116.19
- 今 开114.68
- 成交量 264.62万股
- 最 低 108.48
- 昨 收 114.14
- 总市值 237.14亿
- 52周最高 212.75
- 市盈率 静 --
- 换手率 1.21%
- 52周最低 90.39
- 委 比 90.10%
- 总股本 2.18亿
- 历史最高 212.75
- 量 比 1.18
- 振 幅 6.75%
- 历史最低 2.64
- 每 手 1
- 风险率 30.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅600.93%！Ascendiant Capital上调Aytu BioPharma目标价至15美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14.5美元升至15美元；摩根大通：维持Annexon"超配"评级，目标价从14美元升至15美元
10-01 19:18
$1000 Invested In Insmed 15 Years Ago Would Be Worth This Much Today
Insmed (NASDAQ:INSM) has outperformed the market over the past 15 years by 11.06% on an annualized basis producing an average annual return of 24.7%. Currently, Insmed has a market capitalization of $25.54 billion. Buying $1000 In INSM: If an investor had bought $1000 of INSM stock 15 years ago, it ...
09-28 23:45
美股大行评级 | Meta获4家机构齐升目标价，最高看至995美元！麦当劳遭6家机构下调，最低看至260美元
今日重点评级关注：Canaccord Genuity：维持Aurora Innovation"买入"评级，目标价从15美元升至17美元；摩根大通：维持皇家加勒比邮轮"超配"评级，目标价从345美元升至394美元
09-25 15:55
Goldman Sachs Reinstates Buy on Insmed, Announces $188 Price Target
Goldman Sachs analyst Andrea Newkirk reinstates Insmed (NASDAQ:INSM) with a Buy and announces $188 price target.
09-24 21:42
美股大行评级 | 巴克莱大幅升Strategy目标价至160美元！康宁遭看淡至180美元，较现价仍溢价25%
今日重点评级关注：HC Wainwright & Co.：上调Cardiff Oncology评级至"买入"，目标价9美元；古根海姆：维持Inventiva"买入"评级，目标价从11美元升至14美元
09-16 16:10
Roth Capital Reiterates Buy on Insmed, Lowers Price Target to $198
Roth Capital analyst Adam Walsh reiterates Insmed (NASDAQ:INSM) with a Buy and lowers the price target from $212 to $198.
09-16 00:40
Goldman rebalances its long duration stock basket
The Goldman Sachs equity team has rebalanced its Long Duration Basket amid rising interest rates. Equities usually struggle to digest sharp increases in interest rates, with long duration growth stock...
09-13 22:12
Here's How Much $100 Invested In Insmed 5 Years Ago Would Be Worth Today
Insmed (NASDAQ:INSM) has outperformed the market over the past 5 years by 24.42% on an annualized basis producing an average annual return of 35.99%. Currently, Insmed has a market capitalization of $27.58 billion. Buying $100 In INSM: If an investor had bought $100 of INSM stock 5 years ago, it wou...
09-08 04:45
If You Invested $1000 In Insmed Stock 10 Years Ago, You Would Have This Much Today
Insmed (NASDAQ:INSM) has outperformed the market over the past 10 years by 10.74% on an annualized basis producing an average annual return of 24.29%. Currently, Insmed has a market capitalization of $26.34 billion. Buying $1000 In INSM: If an investor had bought $1000 of INSM stock 10 years ago, it...
08-28 23:30
